Heartflow
HTFL
49.36
-1.33
-2.62%
Heartflow
US · HTFL
#2217 by market cap
Listed 2025
49.36
-1.33
-2.62%
Live - 5344 symbols - heartbeat 378s ago
· 2026-10-08 07:28
Pre-market
49.39
+0.06%
After-hours
49.36
0.00%
- Market cap
- 4.29B
- P/E (TTM)i
- -36.16
- P/Bi
- 15.34
- EPSi
- -1.37
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on HTFL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 106.00% +0.04pp
- Institutions
- 241 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund66.12%
VC/PE Fund25.21%
Hedge Fund10.15%
Individual/Insider6.60%
Public Company2.42%
Private Company0.74%
Insurance Company0.69%
Sovereign Wealth Fund0.34%
Government Pension Fund0.20%
Top holders as of 2026-07-31
Wellington Management Group
10.62% · 9.23M sh
Bain Capital Life Sciences Investors, LLC
9.72% · 8.45M sh
KKR & Co. Inc.
6.30% · 5.47M sh
BlackRock
5.98% · 5.20M sh
FMR
5.54% · 4.82M sh
Vanguard Portfolio Management, LLC
4.12% · 3.58M sh
Lonnie Smith
4.00% · 3.47M sh
Baron Capital Group, Inc.
3.71% · 3.23M sh
USVP Management Company, LLC
3.65% · 3.17M sh
Vanguard Capital Management, LLC
3.44% · 2.99M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 14 buys · 36 sells
| Name | Role | Stake |
|---|---|---|
| John Farquhar | Chief Executive Officer | 0.37% |
| William Weldon | Independent Chairperson | 0.28% |
| Timothy Barabe | Independent Director | 0.22% |
| Campbell Rogers | Chief Medical Officer & Executive VP | 0.19% |
| Vikram Verghese | Chief Financial Officer | 0.09% |
| Julie Cullivan | Independent Director | 0.03% |
| Mhairi Jones | -- | 0.02% |
| Casey Tansey | Independent Director | 0.02% |
| USVP Management Company, LLC | -- | -- |
| HealthCor Management L.P. | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-17 | Campbell Rogers | Chief Medical Officer & Executive VP | Automatic Disposition | -6,503 | $50.15 |
| 2026-09-17 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -13,179 | $2.22–50.15 |
| 2026-09-17 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -24,345 | $50.11–50.75 |
| 2026-09-17 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -16,766 | $50.75 |
| 2026-09-16 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -7,579 | $50.11 |
| 2026-09-14 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -34,975 | $50.01–50.24 |
| 2026-09-14 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -668 | $50.01 |
| 2026-09-13 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -4,593 | $50.24 |
| 2026-09-10 | John Farquhar | Chief Executive Officer | Automatic Disposition | -38,900 | $46.42–50.00 |
| 2026-09-10 | John Farquhar | Chief Executive Officer | Intent to Sell (Form 144) | -3,890 | $50.00 |
| 2026-09-10 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -29,714 | $50.06 |
| 2026-09-09 | John Farquhar | Chief Executive Officer | Intent to Sell (Form 144) | -35,010 | $46.42 |
| 2026-09-07 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -6,640 | $50.03 |
| 2026-09-02 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -33,416 | $49.69–50.60 |
| 2026-09-02 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -27,540 | $49.69 |
| 2026-09-01 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -5,876 | $50.60 |
| 2026-08-20 | John Farquhar | Chief Executive Officer | Automatic Disposition | -27,230 | $50.00 |
| 2026-08-17 | John Farquhar | Chief Executive Officer | Automatic Disposition | -32,676 | $45.00 |
| 2026-08-16 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -9,219 | $19.00–41.23 |
| 2026-08-13 | John Farquhar | Chief Executive Officer | Automatic Disposition | -15,560 | $39.06 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:28:40 · For reference only, not investment advice and not tailored to your situation.